ClearLLab 10C Case Book

M1 Cell Tube

Figure 17. This CD13 vs CD34 dot plot shows all viable cells. CD13 is expressed on granulocytes (blue), monocytes, basophils, and CD34 positive progenitors. CD34 is expressed on early hematopoietic progenitors. The aberrant population (purple) is strongly positive for CD34 and dimly positive for CD13.

Figure 18. This CD14 vs CD64 dot plot shows all viable cells. CD64 is expressed at a high level on monocytes and at a lower level on granulocytes (blue). CD14 is expressed at a high level on monocytes and a lower level on granulocytes (blue). The aberrant population (purple) is negative for CD14 and CD64.

Figure 19. This HLA-DR vs CD10dot plot shows all viable cells. HLA-DR is expressed onmonocytes, B cells, plasmacytoid dendritic cells andCD34 positive progenitors. CD10 is expressed on granulocytes (blue). The aberrant population (purple) is positive for HLA-DR and negative for CD10.

Figure 20. This CD7 vs CD13 dot plot shows all viable cells. CD7 is expressed on T cells and NK cells. CD13 is expressed on granulocytes (blue), monocytes, and basophils, and CD34 positive progenitors. Coexpression of CD13 and CD7 is generally not seen. The aberrant population (purple) is dimly positive for CD13 and negative for CD7.

Table of Contents > Neoplastic Process of B-cell Origin > Case #4: B Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma

Every Event Matters

97

Beckman Coulter • ClearLLab 10C Panels • C30134 AA